Volume 7, Issue 2 (2021)
Pharm Biomed Res 2021, 7(2): 97-104 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rana P, Ghadlinge M, Singh P, Chandane R D, Khanna A. Doctors Perception of the Use of Hydroxychloroquine as Prophylaxis for COVID-19 Infection. Pharm Biomed Res 2021; 7 (2) :97-104
URL: http://pbr.mazums.ac.ir/article-1-372-en.html
URL: http://pbr.mazums.ac.ir/article-1-372-en.html
1- Department of Pharmacology, University College of Medical Sciences, Delhi.
2- Department of Medicine, ABVIMS & Dr RML Hospital, New Delhi, India.
3- Department of Pulmonary Medicine & Critical Care, Yashoda Superspeciality Hospital, Ghaziabad, Uttar Pradesh, India.
2- Department of Medicine, ABVIMS & Dr RML Hospital, New Delhi, India.
3- Department of Pulmonary Medicine & Critical Care, Yashoda Superspeciality Hospital, Ghaziabad, Uttar Pradesh, India.
Abstract: (4206 Views)
Background: The National Task force constituted by the Indian Council of Medical Research (ICMR) and various International agencies has recommended the use of Hydroxychloroquine (HCQ) as prophylaxis for Coronavirus Disease 2019 (COVID-19). This measure was taken because of the urgent need to protect high-risk individuals like Health Care Workers (HCW) from contracting COVID-19.
Objectives: This study aimed to assess the awareness, attitudes, and practices on using HCQ as prophylaxis to prevent COVID-19 infection.
Methods: A cross-sectional study was conducted among the doctors working in Dr RML Hospital, New Delhi, India, a tertiary care public hospital involved in the care of COVID-19 patients. The invitation to participate was electronically circulated, and the consenting participants were allowed to access an online survey. The survey had a total of 23 questions that were designed to understand the awareness, perception, and practices of doctors regarding the use of HCQ as prophylaxis in COVID-19.
Results: About 147 doctors participated in this survey. The major source of knowledge regarding HCQ prophylaxis was quoted as regulatory agencies (44%), particularly ICMR, and the main indication was reported as being a healthcare worker (60%). Most of the participants (91%) believed that the HCQ effect is not clear and felt more scientific data regarding the use of HCQ as prophylaxis for COVID-19. But many doctors (51%) still recommend using HCQ to their colleagues.
Conclusion: In this study, we observed that most doctors were aware of the recommendations regarding the HCQ prophylaxis in COVID-19 and had good adherence to therapy but felt the need for more concrete scientific evidence for using HCQ.
Objectives: This study aimed to assess the awareness, attitudes, and practices on using HCQ as prophylaxis to prevent COVID-19 infection.
Methods: A cross-sectional study was conducted among the doctors working in Dr RML Hospital, New Delhi, India, a tertiary care public hospital involved in the care of COVID-19 patients. The invitation to participate was electronically circulated, and the consenting participants were allowed to access an online survey. The survey had a total of 23 questions that were designed to understand the awareness, perception, and practices of doctors regarding the use of HCQ as prophylaxis in COVID-19.
Results: About 147 doctors participated in this survey. The major source of knowledge regarding HCQ prophylaxis was quoted as regulatory agencies (44%), particularly ICMR, and the main indication was reported as being a healthcare worker (60%). Most of the participants (91%) believed that the HCQ effect is not clear and felt more scientific data regarding the use of HCQ as prophylaxis for COVID-19. But many doctors (51%) still recommend using HCQ to their colleagues.
Conclusion: In this study, we observed that most doctors were aware of the recommendations regarding the HCQ prophylaxis in COVID-19 and had good adherence to therapy but felt the need for more concrete scientific evidence for using HCQ.
Type of Study: Original Research |
Subject:
Pharmacology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Pharmaceutical and Biomedical Research
Faculty of Pharmacy, Mazandaran University of Medical Sciences, Khazar Abad Road (Km-17th), Sari, Iran.
Journal Tel: +98-11-33543762
Website: http://pbr.mazums.ac.ir/
Email: pbrjournal@gmail.com
